SkyCell

PharmaLifeScience News

...

Shionogi gets approval in Japan for ADHD digital therapeutic

A digital therapeutic (DTx) for attention deficit hyperactivity disorder (ADHD) developed by Akili has been approved in Japan, where it will be sold by licensee Shionogi.

READ MORE
...

USAID could see workforce cut to 600 as stop-work looms

The Trump administration intends to keep only 611 essential workers in position at America's foreign aid agency USAID, according to a notice sent to employees that has been shared with Reuters.

READ MORE
...

AstraZeneca, Whitehall, and a failed 450m deal for the next generation in vaccines. What went wrong?

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

READ MORE

Norway: New national cancer strategy presented

AstraZeneca hit with US class action lawsuit over China regulatory probes

Dignitana expands IP with new patent in Korea

OCT West Coast 2025: China surpasses US for annual number of clinical trials

FTC retains stricter merger guidelines under Trump

Amazon joins forces with Memorial Sloan Kettering for AI-powered drug discovery

Generic drugs from India linked to more severe adverse events

Irish exports hit record high with pharmaceuticals showing major boost

Trump’s tariffs will trickle down the clinical trial chain
Ellab